Compliance Action

Ontario's upcoming watchdog report on French-language service gaps reveals deep bureaucratic flaws. Can the province fix its frontline delivery model?

Neogen's Q1 results show promise with raised guidance, but debt, transition costs, and a new FDA warning reveal a steep climb ahead for the company.

In an era of pharmaceutical supply chain disruptions and rising FDA warning letters, one manufacturer's pristine compliance streak offers a rare blueprint.

Following severe adverse events linked to compounded glutathione, industry accreditors are cracking down on the booming, loosely regulated IV therapy market.

As the federal government transitions to automated security validation, a new pilot proves that continuous compliance is the digital backbone of the future.

A multi-agency GCP inspection forces AB Science to delay its lead ALS and AML trials to 2027, testing investor patience and a new turnaround strategy.

Better Home & Finance's AI promised to revolutionize mortgages. Instead, a bitter proxy fight and fiduciary probe reveal the human cost of founder control.

A third-party web vulnerability at a major mail-order pharmacy highlights the hidden supply chain risks threatening patient medical and financial data.

Federal indictments of five Kentucky men reveal a transnational animal-fighting syndicate, exposing the underground logistics of a lucrative global trade.

A Toronto contractor's $20,000 fine for repeated gas pipeline strikes and illegal DIY repairs raises questions about regulatory deterrence in Ontario.

As aging homes crumble and mortgage rates trap owners, fintechs offer debt-free cash. But regulatory crackdowns reveal a steep price for home equity.

A Houston pump maker says it can fulfill a $13M federal contract, directly challenging a waiver request. Is the ‘Buy American’ act working as intended?

Holdun Family Office calls its Bahamas departure a business decision, but regulators allege fraud and mismanagement of funds, including a failed tech fund.

Facing delisting, BioRestorative executes another reverse split. We dive into whether this financial maneuver can sustain it or just delays the inevitable.

A wave of Salmonella and allergen recalls reveals deep cracks in our food supply. We explore the systemic failures and what they mean for your family's safety.

As Boeing celebrates record sales, a string of scrapped jets, rejected deliveries, and silenced whistleblowers reveals a disturbing gap between its financial recovery and manufacturing reality.

A $1.8M settlement between a government contractor and the DOJ seems straightforward. But explosive allegations of retaliation and 'weaponization' by the SEC tell another story.

Unauthorized antibiotics and ED drugs sold from a Montreal store reveal a dangerous black market that bypasses health regulations and puts consumers at risk.

With a 164% surge in subscription revenue and renewed Nasdaq compliance, Cloudastructure is proving its strategic shift to a high-margin, AI-driven future.

DPM Metals celebrates a major production milestone at its Vareš mine, boosting its financials. But a lead contamination crisis threatens its social license.